Skip to main content

Williams Frank J's Form 4 filing

Evolent Health, Inc. (EVH) · filed Aug 25, 2022

Accession no.
0001628908-22-000122
Filed
Aug 25, 2022
Trade date
Aug 23-24, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.22M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Williams Frank JCIK 0001204938Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 23, 2022Class A Common StockMOption exerciseAcquired+150,000$3.84+$576,000902,434Direct
Aug 23, 2022Class A Common StockSSaleDisposed−150,000$35.75−$5,362,500752,434Direct
Aug 24, 2022Class A Common StockMOption exerciseAcquired+50,000$13.95+$697,500802,434Direct
Aug 24, 2022Class A Common StockSSaleDisposed−50,000$37.21−$1,860,500752,434Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 23, 2022Class A Common StockMOption exerciseDisposed−150,000$0.00$0449,060Direct
Aug 24, 2022Class A Common StockMOption exerciseDisposed−50,000$0.00$0177,273Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)